Literature DB >> 19486885

Preliminary validation of ERBB2 expression regulated by miR-548d-3p and miR-559.

Hong Chen1, Jian Guo Sun, Xue-Wu Cao, Xiao-Gan Ma, Jian-Ping Xu, Fu-Kang Luo, Zheng-Tang Chen.   

Abstract

ERBB2 overexpression occurs in numerous types of primary human tumors and alterations in microRNA (miRNA) expression have been associated with tumor suppression or tumorigenesis in human cancer, nevertheless, little is known about natural miRNAs acting on ERBB2. In this study, bioinformatical analysis of the 3'-UTRs of ERBB2 revealed the target elements for miR-548d-3p and miR-559. Moreover, a predicted miRNA/mRNA interaction experimental validation showed that both miR-548d-3p and miR-559 can interact specifically with the 3'-UTR of the ERBB2 mRNA. And miR-548d-3p plus miR-559 transfection showed a cooperative regulation of translationally repressing ERBB2 mRNA rather than by either miR-548d-3p or miR-559 alone. These results not only support the idea that different miRNAs can simultaneously and cooperatively repress a given target mRNA but also preliminarily validate the role of miR-548d-3p and miR-559 in regulating the ERBB2 expression. These data provide molecular basis for the application of miRNAs in ERBB2-targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486885     DOI: 10.1016/j.bbrc.2009.05.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Involvement of microRNAs in HER2 signaling and trastuzumab treatment.

Authors:  Ling Mao; Ai-Jun Sun; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-10-12

2.  MicroRNA-548j functions as a metastasis promoter in human breast cancer by targeting Tensin1.

Authors:  Yun Zhan; Xiaoshuan Liang; Lin Li; Baona Wang; Fang Ding; Yi Li; Xiang Wang; Qimin Zhan; Zhihua Liu
Journal:  Mol Oncol       Date:  2016-02-23       Impact factor: 6.603

3.  MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.

Authors:  Dawn R Cochrane; Diana M Cittelly; Erin N Howe; Nicole S Spoelstra; Erin L McKinsey; Kelly LaPara; Anthony Elias; Douglas Yee; Jennifer K Richer
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

4.  The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.

Authors:  Lyndsay V Rhodes; Ashley M Nitschke; H Chris Segar; Elizabeth C Martin; Jennifer L Driver; Steven Elliott; Seung Yoon Nam; Meng Li; Kenneth P Nephew; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Rep       Date:  2011-10-04       Impact factor: 3.906

Review 5.  The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.

Authors:  A Dittrich; H Gautrey; D Browell; A Tyson-Capper
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-12-28       Impact factor: 2.673

Review 6.  Oncogenes associated with drug resistance in ovarian cancer.

Authors:  Xia Liu; Yutao Gao; Yi Lu; Jian Zhang; Li Li; Fuqiang Yin
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-06       Impact factor: 4.553

7.  MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.

Authors:  Ge Zhao; Ting Wang; Qi-Ke Huang; Meng Pu; Wei Sun; Zhuo-Chao Zhang; Rui Ling; Kai-Shan Tao
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

8.  Systematic analysis of microRNA targeting impacted by small insertions and deletions in human genome.

Authors:  Anindya Bhattacharya; Jesse D Ziebarth; Yan Cui
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

9.  Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.

Authors:  Zhong-Ming Feng; Jun Qiu; Xie-Wan Chen; Rong-Xia Liao; Xing-Yun Liao; Lu-Ping Zhang; Xu Chen; Yan Li; Zheng-Tang Chen; Jian-Guo Sun
Journal:  BMC Cancer       Date:  2015-09-23       Impact factor: 4.430

10.  High-throughput miRNA and mRNA sequencing of paired colorectal normal, tumor and metastasis tissues and bioinformatic modeling of miRNA-1 therapeutic applications.

Authors:  Christina Röhr; Martin Kerick; Axel Fischer; Alexander Kühn; Karl Kashofer; Bernd Timmermann; Andriani Daskalaki; Thomas Meinel; Dmitriy Drichel; Stefan T Börno; Anja Nowka; Sylvia Krobitsch; Alice C McHardy; Christina Kratsch; Tim Becker; Andrea Wunderlich; Christian Barmeyer; Christian Viertler; Kurt Zatloukal; Christoph Wierling; Hans Lehrach; Michal R Schweiger
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.